Analyst consensus rating
Ensysce Biosciences Analyst Rating: Strong Buy
ENSC is rated Strong Buy by 1 analysts with a $8.25 target. As of 2026-08-29.
Direct answer
Ensysce Biosciences's consensus rating is Strong Buy.
1 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $8.25.
Forecast evidence checked August 29, 2026.
Get free Ensysce Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.40
- Average price target
- $8.25
- High price target
- $8.25
- Low price target
- $8.25
- Low target gap
- +1,963%
- Target upside
- +1,963%
- High target gap
- +1,963%
- Target range width
- 0%
- Consensus rating
- Strong Buy
- Analysts
- 1
- Evidence date
- August 29, 2026
- Valid through
- September 5, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Ensysce Biosciences?
Ensysce Biosciences has a verified Strong Buy consensus. The same dataset has an average price target of $8.25.
How far are Ensysce Biosciences's low and high targets from the recorded price?
The low target implies +1,963%, while the high target implies +1,963%.
How many analysts are included in Ensysce Biosciences's consensus?
The verified consensus includes 1 analysts.
How is Ensysce Biosciences's target upside or downside calculated?
The average target of $8.25 is divided by the recorded price of $0.40, then one is subtracted to produce +1,963%. This does not guarantee a future return.
When was Ensysce Biosciences's analyst forecast verified?
The data was verified on 2026-08-29. The dataset is valid through 2026-09-05.